Naelle Lombion

Versailles, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.

Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.

Journal: Platelets
Published: February 28, 2022

Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria.

Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria.

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
Published: February 08, 2022

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.

Journal: Blood
Published: October 28, 2021

A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia.

A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia.

Journal: Haematologica
Published: September 17, 2021

Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience.

Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience.

Journal: Blood
Published: February 21, 2021

Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma.

Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma.

Journal: British journal of haematology
Published: February 04, 2020

Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature.

Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature.

Journal: British journal of haematology
Published: December 17, 2019

MUB40 Binds to Lactoferrin and Stands as a Specific Neutrophil Marker.

MUB40 Binds to Lactoferrin and Stands as a Specific Neutrophil Marker.

Journal: Cell chemical biology
Published: September 29, 2017
Showing 1-8 of 8

Last Updated: 09/26/2026